ArticleTheranostics2019

Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.

Yong Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.